Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Epichlorohydrin. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102838511A reveals a cost-effective Sitagliptin intermediate route avoiding expensive catalysts. Enhance supply chain reliability with scalable chemistry.
Patent CN1233648C reveals a novel salen catalyst enabling reusable, high-optical-purity epoxide production with significant cost and supply chain advantages.
Patent CN1463272A reveals a novel chiral salen catalyst enabling racemization-free production of chiral epoxides with enhanced supply chain reliability and cost efficiency.
Patent CN103025692A reveals a novel glycerol hydrochlorination process offering superior selectivity and reduced waste for reliable fine chemical intermediates supply chains.
Patent CN101337950A details a continuous glycerol hydrochlorination process for epichlorohydrin. This report analyzes the cost-effective, eco-friendly catalytic route for reliable supply chain integration.
Patent CN102994470A details a novel Aus EH-B enzyme for high-purity chiral epichlorohydrin. Discover cost-effective biocatalytic solutions for pharmaceutical intermediates.
Patent CN105734028A reveals high-efficiency epoxide hydrolase mutants for R-epichlorohydrin production, offering superior stability and supply chain reliability.
Patent CN105734028A reveals mutant epoxide hydrolase for high-purity R-epichlorohydrin. Enhances stability and activity for reliable pharmaceutical intermediate supply chains.
Patent CN100408555C reveals a high-yield synthesis of 4-chloro-3-hydroxybutyronitrile using basic catalysts, offering significant cost reduction and waste minimization for supply chains.
Patent CN117105887A reveals a novel Salen Co-catalyzed resolution for chiral epichlorohydrin. Achieve high purity, catalyst recycling, and significant cost reduction in pharmaceutical manufacturing.